ANTH
Anthera Pharmaceuticals, Inc.
ANTH
ANTH
Delisted
ANTH was delisted on the 27th of June, 2018.
43 hedge funds and large institutions have $65.9M invested in Anthera Pharmaceuticals, Inc. in 2015 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 17 increasing their positions, 8 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
18% less call options, than puts
Call options by funds: $321K | Put options by funds: $392K
Holders
43
Holding in Top 10
1
Calls
$321K
Puts
$392K
Top Buyers
| 1 | +$4.92M | |
| 2 | +$4.25M | |
| 3 | +$3.18M | |
| 4 |
PAI
ProQuest Associates IV
Naples,
Florida
|
+$2.91M |
| 5 |
BC
Broadfin Capital
New York
|
+$2.85M |
Top Sellers
| 1 | -$2.67M | |
| 2 | -$884K | |
| 3 | -$447K | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$395K |
| 5 |
SIM
Spark Investment Management
New York
|
-$387K |